Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Reduction of non-specific binding in immunoassays requiring long incubations.

Farajollahi MM, Cook DB, Hamzehlou S, Self CH.

Scand J Clin Lab Invest. 2012 Nov;72(7):531-9. doi: 10.3109/00365513.2012.702352. Epub 2012 Aug 31.

PMID:
22939169
2.

Light-activated antibodies in the fight against primary and metastatic cancer.

Thompson S, Self AC, Self CH.

Drug Discov Today. 2010 Jun;15(11-12):468-73. doi: 10.1016/j.drudis.2010.04.006. Epub 2010 May 8. Review.

PMID:
20450983
3.
4.

The construction and in vitro testing of photo-activatable cancer targeting folated anti-CD3 conjugates.

Thompson S, Dessi J, Self CH.

Biochem Biophys Res Commun. 2008 Feb 8;366(2):526-31. Epub 2007 Dec 7.

PMID:
18068664
5.

Light activation of anti-CD3 in vivo reduces the growth of an aggressive ovarian carcinoma.

Thompson S, Stewart R, Smith JA, Self CH.

ChemMedChem. 2007 Nov;2(11):1591-3. No abstract available.

PMID:
17979166
6.

Light-directed activation of human T-cells.

Self CH, Self AC, Smith JA, Self DJ, Thompson S.

ChemMedChem. 2007 Nov;2(11):1587-90. No abstract available.

PMID:
17979165
7.

The construction of a functional photoactivatable cancer targeting bispecific antibody conjugate.

Thompson S, Fawcett MC, Self CH.

ChemMedChem. 2007 Aug;2(8):1162-4. No abstract available.

PMID:
17506043
8.

How specific are therapeutic monoclonal antibodies?

Self CH, Thompson S.

Lancet. 2006 Apr 1;367(9516):1038-1039. doi: 10.1016/S0140-6736(06)68396-7. No abstract available.

PMID:
16581388
9.

A simple procedure for the photoregulation of chymotrypsin activity.

Thompson S, Fawcett MC, Pulman LB, Self CH.

Photochem Photobiol Sci. 2006 Mar;5(3):326-30. Epub 2006 Jan 19.

PMID:
16520868
10.

The first monoclonal antibody-based, matrix-resistant immunoassay for the carbamate herbicide asulam, in water.

Spoors JA, Winger LA, Siew LK, Dessi JL, Jennens L, Self CH.

J Environ Monit. 2002 Dec;4(6):917-21.

PMID:
12509045
11.

Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.

Fleming SC, Smith S, Knowles D, Skillen A, Self CH.

J Clin Pathol. 1998 Nov;51(11):825-30.

12.

Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls.

Cook DB, Bustamam AA, Brotherick I, Shenton BK, Self CH.

Clin Chem. 1999 Feb;45(2):292-5. No abstract available.

13.

Major improvement of lectin-based assays through choice of cation and optimization of cation concentration.

Farajollahi MM, Cook DB, Self CH.

Anal Biochem. 1998 Jul 15;261(1):118-21. No abstract available.

PMID:
9683521
14.

A sandwich hybridization assay employing enzyme amplification for termination of specific ribosomal RNA from unpurified cell lysates.

Wicks B, Cook DB, Barer MR, O'Donnell AG, Self CH.

Anal Biochem. 1998 Jun 1;259(2):258-64.

PMID:
9618205
15.

Characterization of corticotropin-releasing hormone binding sites in the human placenta.

Saeed BO, Weightman DR, Self CH.

J Recept Signal Transduct Res. 1997 Jul;17(4):647-66.

PMID:
9220373
16.
17.
18.

Light activatable antibodies: models for remotely activatable proteins.

Self CH, Thompson S.

Nat Med. 1996 Jul;2(7):817-20.

PMID:
8673931
19.

Advances in immunoassay technology.

Self CH, Cook DB.

Curr Opin Biotechnol. 1996 Feb;7(1):60-5. Review.

PMID:
8742378
20.

Studies on photocleavable nitrobenzyl-bovine serum albumin conjugates.

Self CH, Fawcett MC, Spoors JA, Pulman LB, Thompson S.

Biochem Soc Trans. 1995 May;23(2):156S. No abstract available.

PMID:
7672187
21.

The modulation of protein A-IgG(Fc) binding by the reversible addition of 2-nitrobenzyl groups.

Thompson S, Fawcett MC, Spoors JA, Self CH.

Biochem Soc Trans. 1995 May;23(2):155S. No abstract available.

PMID:
7672186
22.

Glycation of monoclonal antibodies impairs their ability to bind antigen.

Kennedy DM, Skillen AW, Self CH.

Clin Exp Immunol. 1994 Nov;98(2):245-51.

24.

Photocleavable nitrobenzyl-protein conjugates.

Thompson S, Spoors JA, Fawcett MC, Self CH.

Biochem Biophys Res Commun. 1994 Jun 30;201(3):1213-9.

PMID:
8024564
25.
26.

Glycation increases the vascular clearance rate of IgG in mice.

Kennedy DM, Skillen AW, Self CH.

Clin Exp Immunol. 1993 Dec;94(3):447-51.

27.

Colorimetric assay of glycoprotein glycation free of interference from glycosylation residues.

Kennedy DM, Skillen AW, Self CH.

Clin Chem. 1993 Nov;39(11 Pt 1):2309-11.

30.

Monosaccharide composition of haptoglobin purified from alcoholic cirrhotic and control sera determined by HPAE.

Mann AC, Thompson S, Record CO, Self CH, Turner GA.

Biochem Soc Trans. 1993 May;21(2):214S. No abstract available.

PMID:
8359464
31.
32.

Electrochemical sensors for direct reagentless measurement of superoxide production by human neutrophils.

McNeil CJ, Greenough KR, Weeks PA, Self CH, Cooper JM.

Free Radic Res Commun. 1992;17(6):399-406.

PMID:
1337538
33.

The effects of rat corticotrophin-releasing factor-41 Peptide fragments on bioassay and immunoassay determination of corticotrophin-releasing factor-41 levels.

Milton NG, Nicholson SA, Self CH, Hillhouse EW.

J Neuroendocrinol. 1990 Dec 1;2(6):897-901. doi: 10.1111/j.1365-2826.1990.tb00657.x.

PMID:
19215435
34.

Corticotrophin-releasing factor-41 in the human and rat-utility of a highly sensitive enzyme amplified immunometric assay.

Milton NG, Hillhouse EW, Fuller JQ, Self CH.

J Neuroendocrinol. 1990 Dec 1;2(6):889-95. doi: 10.1111/j.1365-2826.1990.tb00656.x.

PMID:
19215434
35.

Production and utilization of monoclonal antibodies to human/rat corticotrophin-releasing factor-41.

Milton NG, Hillhouse EW, Nicholson SA, Self CH, McGregor AM.

J Mol Endocrinol. 1990 Oct;5(2):159-66.

PMID:
2248688
36.
37.
38.

A sensitive and specific two-site enzyme-immunoassay for human calcitonin using monoclonal antibodies.

Seth R, Motté P, Kehely A, Wimalawansa SJ, Self CH, Bellet D, Bohuon C, MacIntyre I.

J Endocrinol. 1988 Nov;119(2):351-7.

PMID:
3058855
39.

A highly specific and sensitive enzyme-immunometric assay for calcitonin gene-related peptide based on enzyme amplification.

Seth R, Zaidi M, Fuller JQ, Self CH.

J Immunol Methods. 1988 Jun 28;111(1):11-6.

PMID:
3260611
40.

Calcitonin determination by a fast and highly sensitive enzyme amplified immunoassay.

Lynch C, Seth R, Bates DL, Self CH.

J Immunoassay. 1988;9(2):179-92.

PMID:
3286683
41.

An enzyme-amplified monoclonal immunoenzymometric assay for prostatic acid phosphatase.

Moss DW, Self CH, Whitaker KB, Bailyes E, Siddle K, Johannsson A, Stanley CJ, Cooper EH.

Clin Chim Acta. 1985 Oct 31;152(1-2):85-94.

PMID:
2414044
42.

Enzyme amplification can enhance both the speed and the sensitivity of immunoassays.

Stanley CJ, Johannsson A, Self CH.

J Immunol Methods. 1985 Oct 24;83(1):89-95.

PMID:
3902974
43.

Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene.

Girgis SI, Macdonald DW, Stevenson JC, Bevis PJ, Lynch C, Wimalawansa SJ, Self CH, Morris HR, MacIntyre I.

Lancet. 1985 Jul 6;2(8445):14-6.

PMID:
2861456
44.

A new sensitive and fast peptide immunoassay based on enzyme amplification used in the determination of CGRP and the demonstration of its presence in the thyroid.

Self CH, Wimalawansa SJ, Johannsson A, Bates DL, Girgis SI, Macintyre I.

Peptides. 1985 Jul-Aug;6(4):627-30.

PMID:
3906592
45.
46.
47.

Serum thyrotropin: a first-line discriminatory test of thyroid function.

Roddis MJ, Burrin JM, Johannssen A, Ellis DH, Self CH.

Lancet. 1985 Feb 2;1(8423):277-8. No abstract available.

PMID:
2857342
49.

Solid phase assay of radioactive antibody to soluble antigens.

Self CH, Tew JG, Cook RG, Stavitsky AB.

Immunochemistry. 1974 May;11(5):227-33. No abstract available.

PMID:
4415806
50.

The spontaneous induction of anamnestic antibody synthesis in lymph node cell cultures many months after primary immunization.

Tew JG, Self CH, Harold WW, Stavitsky AB.

J Immunol. 1973 Aug;111(2):416-23. No abstract available.

PMID:
4717987

Supplemental Content

Support Center